BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation

6d ago, source:

BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced ...

Interview with the President and CEO: BioVie Inc. (NASDAQ:BIVI)

6d ago, source: The Wall Street Transcript

Let’s start with a brief overview and history of the company. Mr. Do: BioVie was started by Jonathan Adams to develop a drug called terlipressin to treat ascites, which is end stage liver disease. I ...

Bears are Losing Control Over BioVie Inc. (BIVI), Here's Why It's a 'Buy' Now

1mon ago, source: Zacks.com on MSN

T he price trend for BioVie Inc. (BIVI) has been bearish lately and the stock has lost 34.8% over the past week. However, the formation of a hammer chart pattern in its last trading session ...

Why BioVie Shares Are Trading Lower By Around 42%; Here Are 20 Stocks Moving Premarket

on MSN ago, source:

Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public ...

BioVie Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BIVI

1mon ago, source: Stockhouse

THE LAWSUIT: A class action securities lawsuit was filed against BioVie Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between August 5, 2021 ...

Lawsuit Notice: Investors who lost money with BioVie Inc. (NASDAQ: BIVI) shares should contact the Shareholders Foundation

29d ago, source: Morningstar

SAN DIEGO, March 26, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in BioVie Inc. (NASDAQ: BIVI) shares. Investors, who ...

BioVie Inc. Announces Pricing of Public Offering

1mon ago, source: Nasdaq

CARSON CITY, Nev., March 04, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative ...

BioVie Inc. Announces Proposed Public Offering of Common Stoc

1mon ago, source: Morningstar

Morningstar brands and products Company Get 7 Days Free ...

BioVie Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

BioVie Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - BIVI

1mon ago, source: Business Insider

NEW YORK, NY / ACCESSWIRE / March 10, 2024 / If you suffered a loss on your BioVie Inc. (NASDAQ:BIVI) investment and want to learn about a potential recovery under the federal securities laws ...